Esophageal, gastric and colorectal cancers: Looking beyond classical serological biomarkers towards glycoproteomics-assisted precision oncology.


Journal

Theranostics
ISSN: 1838-7640
Titre abrégé: Theranostics
Pays: Australia
ID NLM: 101552395

Informations de publication

Date de publication:
2020
Historique:
received: 26 11 2019
accepted: 16 01 2020
entrez: 21 4 2020
pubmed: 21 4 2020
medline: 10 4 2021
Statut: epublish

Résumé

Esophageal (OC), gastric (GC) and colorectal (CRC) cancers are amongst the digestive track tumors with higher incidence and mortality due to significant molecular heterogeneity. This constitutes a major challenge for patients' management at different levels, including non-invasive detection of the disease, prognostication, therapy selection, patient's follow-up and the introduction of improved and safer therapeutics. Nevertheless, important milestones have been accomplished pursuing the goal of molecular-based precision oncology. Over the past five years, high-throughput technologies have been used to interrogate tumors of distinct clinicopathological natures, generating large-scale biological datasets (

Identifiants

pubmed: 32308758
doi: 10.7150/thno.42480
pii: thnov10p4903
pmc: PMC7163443
doi:

Substances chimiques

Antigens, Tumor-Associated, Carbohydrate 0
Glycoproteins 0
Sialyl Lewis X Antigen 0
sialosyl-Tn antigen 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

4903-4928

Informations de copyright

© The author(s).

Déclaration de conflit d'intérêts

Competing Interests: The authors have declared that no competing interest exists.

Références

Cancer Res. 2010 May 15;70(10):4064-73
pubmed: 20460514
Curr Pathobiol Rep. 2018;6(4):275-286
pubmed: 30595972
Oncotarget. 2016 Dec 13;7(50):83570-83587
pubmed: 27835877
Clin Cancer Res. 2011 Mar 1;17(5):1024-32
pubmed: 21343375
Sci Rep. 2018 Feb 9;8(1):2732
pubmed: 29426902
J Clin Oncol. 2006 Nov 20;24(33):5313-27
pubmed: 17060676
Glycobiology. 2019 May 1;29(5):349-354
pubmed: 30778580
Oncologist. 2011;16(8):1092-100
pubmed: 21572124
Mol Oncol. 2014 May;8(3):753-65
pubmed: 24656965
Oncol Rep. 2001 Sep-Oct;8(5):981-5
pubmed: 11496302
Onco Targets Ther. 2018 Nov 21;11:8239-8250
pubmed: 30538493
Theranostics. 2019 Oct 11;9(24):7431-7446
pubmed: 31695778
Eur J Surg Oncol. 1995 Apr;21(2):168-75
pubmed: 7720892
Int J Cancer. 1986 Nov 15;38(5):643-50
pubmed: 2429933
J Immunol. 2012 May 1;188(9):4690-700
pubmed: 22467657
Nat Rev Gastroenterol Hepatol. 2017 Jun;14(6):333-342
pubmed: 28400627
Sci Rep. 2018 Aug 15;8(1):12196
pubmed: 30111774
Int Biol Biomed J. 2017 Summer;3(3):105-111
pubmed: 28825047
Nat Med. 2015 May;21(5):449-56
pubmed: 25894828
World J Gastroenterol. 2016 Oct 21;22(39):8770-8778
pubmed: 27818592
Anticancer Res. 2004 Jul-Aug;24(4):2541-6
pubmed: 15330211
Cancer. 1995 Apr 15;75(8):2051-6
pubmed: 7697593
Glycobiology. 2001 Jul;11(7):587-92
pubmed: 11447138
J Biol Chem. 1982 Dec 10;257(23):14365-9
pubmed: 7142214
Oncotarget. 2017 Dec 14;9(6):7204-7218
pubmed: 29467962
J Cancer. 2013 Aug 22;4(7):577-84
pubmed: 23983823
Nat Rev Cancer. 2011 Feb;11(2):123-34
pubmed: 21258396
Chem Soc Rev. 2013 May 21;42(10):4421-42
pubmed: 23440054
Gastroenterology. 1996 Mar;110(3):694-704
pubmed: 8608878
Glycobiology. 2016 Jul;26(7):684-692
pubmed: 26873173
Gastroenterol Jpn. 1991 Jun;26(3):303-11
pubmed: 1716232
Blood Cancer J. 2018 Aug 22;8(9):81
pubmed: 30190468
Cancer Immunol Immunother. 2009 Sep;58(9):1397-405
pubmed: 19190907
Drug Resist Updat. 2016 Jan;24:34-54
pubmed: 26830314
PLoS One. 2012;7(3):e33191
pubmed: 22427986
Biomolecules. 2016 Jul 30;6(3):
pubmed: 27483328
Oncology. 1998 Jan-Feb;55(1):70-6
pubmed: 9428379
Int J Clin Exp Pathol. 2015 Sep 01;8(9):11549-54
pubmed: 26617889
Cancer Res. 2000 Mar 1;60(5):1410-6
pubmed: 10728707
Chembiochem. 2014 Jul 7;15(10):1508-13
pubmed: 24890740
Annu Rev Anal Chem (Palo Alto Calif). 2016 Jun 12;9(1):521-45
pubmed: 27049631
Chang Gung Med J. 2007 May-Jun;30(3):189-209
pubmed: 17760270
Cancer Res. 1989 Jan 1;49(1):197-204
pubmed: 2908846
J Immunol. 2007 Aug 15;179(4):2380-8
pubmed: 17675499
Nat Commun. 2018 Mar 8;9(1):1012
pubmed: 29520031
Cancer Invest. 2005;23(4):338-51
pubmed: 16100946
Trends Cell Biol. 2011 Mar;21(3):149-58
pubmed: 21145746
Vaccines (Basel). 2016 Jul 26;4(3):
pubmed: 27472370
Biochem Soc Trans. 2018 Jun 19;46(3):659-668
pubmed: 29784646
Chem Sci. 2019 Aug 23;10(40):9302-9307
pubmed: 32110292
Proc Natl Acad Sci U S A. 2013 Aug 20;110(34):E3152-61
pubmed: 23912186
Biochim Biophys Acta. 2008 Mar;1780(3):520-4
pubmed: 18036567
J Surg Oncol. 2013 Jul;108(1):14-8
pubmed: 23681672
Electrophoresis. 2010 Jun;31(11):1833-41
pubmed: 20446296
JCI Insight. 2019 Jun 13;5:
pubmed: 31194699
Oncotarget. 2017 Jul 21;8(53):91734-91764
pubmed: 29207682
Methods Mol Biol. 2013;1022:387-402
pubmed: 23765677
J Proteome Res. 2014 Jun 6;13(6):2715-23
pubmed: 24792918
Anal Bioanal Chem. 2017 Jan;409(2):355-357
pubmed: 27933360
Blood. 2000 Sep 1;96(5):1789-97
pubmed: 10961878
Oncology. 2004;67(2):159-65
pubmed: 15539921
J Surg Oncol. 1994 May;56(1):7-12
pubmed: 8176946
J Proteome Res. 2014 Nov 7;13(11):4808-20
pubmed: 25134008
Cancer Res. 1988 Aug 15;48(16):4588-96
pubmed: 3396010
Proc Natl Acad Sci U S A. 2014 Sep 30;111(39):E4066-75
pubmed: 25118277
Virchows Arch. 1997 Jul;431(1):25-30
pubmed: 9273115
J Clin Invest. 2008 Jun;118(6):2325-36
pubmed: 18483624
Cancer Res. 1983 Nov;43(11):5489-92
pubmed: 6193872
Cancer Lett. 2017 Feb 28;387:32-45
pubmed: 26828132
MAbs. 2017 May/Jun;9(4):615-627
pubmed: 28281872
Cancer Res. 2004 Jul 1;64(13):4498-505
pubmed: 15231659
Biol Chem. 2004 Feb;385(2):145-52
pubmed: 15101557
J Cancer. 2014 Mar 15;5(4):262-71
pubmed: 24790654
J Cancer Res Ther. 2014 Nov;10 Suppl:C179-85
pubmed: 25450279
Mass Spectrom (Tokyo). 2017;6(1):A0060
pubmed: 28794918
Cancer Res. 1993 Apr 1;53(7):1706-8
pubmed: 8453646
Electrophoresis. 2015 Dec;36(23):2902-7
pubmed: 26333169
Int J Mol Sci. 2016 Feb 24;17(3):275
pubmed: 26927062
Int J Mol Sci. 2017 Oct 28;18(11):
pubmed: 29143776
Urol Oncol. 2017 Dec;35(12):675.e1-675.e8
pubmed: 28911924
J Microbiol. 2007 Dec;45(6):572-7
pubmed: 18176543
Cancer Sci. 2010 Mar;101(3):586-93
pubmed: 20085584
Clin Chem. 1996 Oct;42(10):1589-600
pubmed: 8855140
Cancer Cell. 2019 Jul 8;36(1):6-16
pubmed: 31287993
Glycoconj J. 1997 Aug;14(5):549-60
pubmed: 9298687
Sci Rep. 2015 Jun 08;5:10775
pubmed: 26053859
Cancers (Basel). 2019 Feb 23;11(2):
pubmed: 30813420
Cancer Metastasis Rev. 2012 Dec;31(3-4):501-18
pubmed: 22699311
Cancer. 1995 Nov 1;76(9):1529-36
pubmed: 8635053
J Gastroenterol. 2001 Dec;36(12):823-9
pubmed: 11777210
Interface Focus. 2019 Apr 6;9(2):20180077
pubmed: 30842876
Cancer Res. 2018 Nov 15;78(22):6349-6353
pubmed: 30442814
J Clin Pathol. 2010 Apr;63(4):322-9
pubmed: 20354203
Br J Cancer. 1995 Jan;71(1):191-5
pubmed: 7819038
Oncol Rep. 2014 May;31(5):2115-22
pubmed: 24626880
Mol Cell Proteomics. 2015 Jun;14(6):1616-29
pubmed: 25813380
Biochem Biophys Res Commun. 2019 Jan 29;509(1):133-137
pubmed: 30579602
J Surg Oncol. 1997 Dec;66(4):238-43
pubmed: 9425326
Int J Cancer. 1998 Aug 21;79(4):402-10
pubmed: 9699534
Sci Rep. 2017 Sep 14;7(1):11563
pubmed: 28912543
Br J Cancer. 2000 Dec;83(12):1681-7
pubmed: 11104566
Cancer Immunol Res. 2019 Jan;7(1):113-122
pubmed: 30413430
Int J Cancer. 2011 Apr 15;128(8):1860-71
pubmed: 21344374
Int J Cancer. 1982 May 15;29(5):539-45
pubmed: 6284656
Clin Proteomics. 2015 Jun 27;12(1):17
pubmed: 26157355
Cancer Sci. 2004 May;95(5):377-84
pubmed: 15132763
Nat Rev Immunol. 2018 Mar;18(3):204-211
pubmed: 29398707
J Pharm Sci. 2009 Apr;98(4):1223-45
pubmed: 18661536
Front Biosci (Landmark Ed). 2012 Jan 01;17:670-99
pubmed: 22201768
Sci Rep. 2019 Feb 26;9(1):2749
pubmed: 30808902
World J Gastroenterol. 2018 Sep 14;24(34):3834-3848
pubmed: 30228778
Int J Oncol. 2000 Oct;17(4):701-5
pubmed: 10995880
Biomolecules. 2016 Jul 11;6(3):
pubmed: 27409642
Gut. 2011 Nov;60(11):1449-72
pubmed: 21705456
Biology (Basel). 2017 Feb 23;6(1):
pubmed: 28241499
FEBS Lett. 2019 Jul;593(13):1675-1689
pubmed: 31077346
Cancers (Basel). 2016 Apr 22;8(4):
pubmed: 27110823
Infect Immun. 2008 Sep;76(9):3992-9
pubmed: 18519558
N Biotechnol. 2019 Mar 25;49:77-87
pubmed: 30273682
Cancer. 1991 Mar 15;67(6):1576-87
pubmed: 2001547
Cancer Res. 1993 Jan 15;53(2):354-61
pubmed: 7678075
Biomolecules. 2012 Oct 11;2(4):435-66
pubmed: 24970145
Oncol Rep. 2003 Jul-Aug;10(4):991-5
pubmed: 12792758
Theranostics. 2016 May 24;6(8):1190-204
pubmed: 27279911
Oncotarget. 2017 Jul 18;8(29):47330-47343
pubmed: 28537884
Cancers (Basel). 2019 May 27;11(5):
pubmed: 31137895
Dis Markers. 2015;2015:549843
pubmed: 26576068
Ann Pathol. 2011 Nov;31(5 Suppl):S27-31
pubmed: 22054452
Theranostics. 2015 Jan 01;5(3):267-76
pubmed: 25553114
PLoS One. 2016 Jan 20;11(1):e0145920
pubmed: 26788922
Cancer Lett. 2007 May 8;249(2):157-70
pubmed: 16965854
Oncotarget. 2016 Sep 27;7(39):63138-63157
pubmed: 27542232
J Control Release. 2015 Jul 10;209:288-307
pubmed: 25957905
Mol Oncol. 2017 Aug;11(8):895-912
pubmed: 28156048
Clin Exp Metastasis. 2012 Mar;29(3):229-38
pubmed: 22228572
PLoS One. 2017 Nov 15;12(11):e0188139
pubmed: 29141049
Int J Biol Markers. 1997 Apr-Jun;12(2):68-74
pubmed: 9342635
Int J Mol Sci. 2013 Jul 26;14(8):15636-54
pubmed: 23896595
Open Med (Wars). 2018 May 9;13:164-171
pubmed: 29756052
Proc Natl Acad Sci U S A. 2012 May 15;109(20):7776-81
pubmed: 22547830
Gastroenterology. 1997 Oct;113(4):1163-70
pubmed: 9322511
Sci China Life Sci. 2018 Nov;61(11):1389-1395
pubmed: 30076562
Cancer Res. 2008 Mar 15;68(6):1636-46
pubmed: 18339842
Oncotarget. 2017 Nov 8;8(68):112550-112564
pubmed: 29348846
Cancer Res. 1988 Apr 15;48(8):2214-20
pubmed: 2450649
Nat Genet. 2015 Sep;47(9):1038-1046
pubmed: 26192915
Nat Rev Cancer. 2015 Sep;15(9):540-55
pubmed: 26289314
J Proteome Res. 2013 Mar 1;12(3):1454-66
pubmed: 23312025
Cancer Res. 2004 Oct 1;64(19):7050-7
pubmed: 15466199
Cancer Res. 1992 Oct 15;52(20):5663-7
pubmed: 1394190
Cancer Res. 1992 Mar 1;52(5):1222-7
pubmed: 1737383
Oncologist. 2014 Nov;19(11):1156-68
pubmed: 25326159
Oncotarget. 2017 Nov 3;9(1):1380-1402
pubmed: 29416702
J Immunother Cancer. 2017 Mar 21;5:22
pubmed: 28344808
Sci Data. 2019 Jul 5;6(1):116
pubmed: 31278253
Adv Cancer Res. 2015;126:53-135
pubmed: 25727146
Glycoconj J. 1998 Jan;15(1):29-35
pubmed: 9530954
EBioMedicine. 2019 Feb;40:349-362
pubmed: 30662000
Cancer Res. 2018 Jul 1;78(13):3574-3588
pubmed: 29703719
J Immunol. 2005 Jun 15;174(12):7764-72
pubmed: 15944279
Urol Oncol. 2018 May;36(5):221-236
pubmed: 29530466
Cancer Metastasis Rev. 1992 Nov;11(3-4):325-51
pubmed: 1423821
J Biol Chem. 1987 Nov 15;262(32):15649-58
pubmed: 2960671
Cancer Cell. 2019 Jan 14;35(1):111-124.e10
pubmed: 30645970
Br J Cancer. 1993 Jul;68(1):130-6
pubmed: 8318403
Cell. 2019 May 2;177(4):1035-1049.e19
pubmed: 31031003
Breast Care (Basel). 2014 Feb;9(1):16-21
pubmed: 24803882
Cancer Res. 1997 Dec 1;57(23):5201-6
pubmed: 9393734
Dis Colon Rectum. 1997 Oct;40(10 Suppl):S37-42
pubmed: 9378010
Int J Mol Sci. 2018 Feb 15;19(2):
pubmed: 29462882
CA Cancer J Clin. 2018 Nov;68(6):394-424
pubmed: 30207593
Int J Cancer. 1996 Jan 26;65(3):295-300
pubmed: 8575847
Oncology. 1999 Jul;57(1):70-6
pubmed: 10394128
Int J Mol Sci. 2018 Nov 23;19(12):
pubmed: 30477151
Biomolecules. 2015 Aug 11;5(3):1783-809
pubmed: 26270678
Cancer. 1998 Dec 15;83(12):2456-67
pubmed: 9874449
Am J Gastroenterol. 1994 Jan;89(1):101-5
pubmed: 8273774
Cancer Immunol Res. 2015 Feb;3(2):173-83
pubmed: 25387893
Int J Biol Markers. 1992 Jul-Sep;7(3):160-6
pubmed: 1431339
EMBO J. 2013 May 15;32(10):1478-88
pubmed: 23584533
Oncotarget. 2017 Feb 14;8(7):11094-11104
pubmed: 28052004
Histol Histopathol. 2011 Oct;26(10):1305-16
pubmed: 21870334
Gastric Cancer. 2014 Jan;17(1):26-33
pubmed: 23572188
Int J Mol Sci. 2019 Mar 14;20(6):
pubmed: 30875739
Cancer Cell. 2018 Feb 12;33(2):187-201.e10
pubmed: 29438695
Am J Gastroenterol. 1991 Sep;86(9):1163-6
pubmed: 1882795
Clin Cancer Res. 2000 Oct;6(10):4017-25
pubmed: 11051251
Nat Rev Cancer. 2017 May;17(5):302-317
pubmed: 28303905
Anticancer Res. 2001 May-Jun;21(3C):2189-93
pubmed: 11501845
Surg Today. 1998;28(7):682-6
pubmed: 9697259
J Proteome Res. 2008 Apr;7(4):1693-703
pubmed: 18311904
Front Biosci (Elite Ed). 2011 Jun 01;3:1443-55
pubmed: 21622148
Front Oncol. 2019 May 14;9:380
pubmed: 31157165
J Biol Chem. 2011 Jun 17;286(24):21052-61
pubmed: 21521691
Trends Mol Med. 2013 Nov;19(11):664-76
pubmed: 23932995
J Am Osteopath Assoc. 2012 Aug;112(8):482-3
pubmed: 22904244
Mol Cell Proteomics. 2014 Dec;13(12):3224-35
pubmed: 25092905
Cancer Res. 1986 Jun;46(6):3118-24
pubmed: 3516392

Auteurs

Elisabete Fernandes (E)

Experimental Pathology and Therapeutics Group, Portuguese Institute of Oncology, 4200-162 Porto, Portugal.
Institute of Biomedical Sciences Abel Salazar (ICBAS), University of Porto, 4050-013 Porto, Portugal.
Institute for Research and Innovation in Health (i3s) , University of Porto, 4200-135 Porto, Portugal.
Institute for Biomedical Engineering (INEB), Porto, Portugal, 4200-135 Porto, Portugal.
Digestive Cancer Research Group, 1495-161 Algés, Portugal.
Porto Comprehensive Cancer Centre (P.ccc), 4200-162 Porto, Portugal.

Janine Sores (J)

Experimental Pathology and Therapeutics Group, Portuguese Institute of Oncology, 4200-162 Porto, Portugal.
Institute of Biomedical Sciences Abel Salazar (ICBAS), University of Porto, 4050-013 Porto, Portugal.
Porto Comprehensive Cancer Centre (P.ccc), 4200-162 Porto, Portugal.
QOPNA/LAQV, Departamento de Química da Universidade de Aveiro, Aveiro, Portugal.

Sofia Cotton (S)

Experimental Pathology and Therapeutics Group, Portuguese Institute of Oncology, 4200-162 Porto, Portugal.
Institute of Biomedical Sciences Abel Salazar (ICBAS), University of Porto, 4050-013 Porto, Portugal.
Porto Comprehensive Cancer Centre (P.ccc), 4200-162 Porto, Portugal.

Andreia Peixoto (A)

Experimental Pathology and Therapeutics Group, Portuguese Institute of Oncology, 4200-162 Porto, Portugal.
Institute of Biomedical Sciences Abel Salazar (ICBAS), University of Porto, 4050-013 Porto, Portugal.
Institute for Research and Innovation in Health (i3s) , University of Porto, 4200-135 Porto, Portugal.
Institute for Biomedical Engineering (INEB), Porto, Portugal, 4200-135 Porto, Portugal.
Porto Comprehensive Cancer Centre (P.ccc), 4200-162 Porto, Portugal.

Dylan Ferreira (D)

Experimental Pathology and Therapeutics Group, Portuguese Institute of Oncology, 4200-162 Porto, Portugal.
Digestive Cancer Research Group, 1495-161 Algés, Portugal.
Porto Comprehensive Cancer Centre (P.ccc), 4200-162 Porto, Portugal.

Rui Freitas (R)

Experimental Pathology and Therapeutics Group, Portuguese Institute of Oncology, 4200-162 Porto, Portugal.
Porto Comprehensive Cancer Centre (P.ccc), 4200-162 Porto, Portugal.
QOPNA/LAQV, Departamento de Química da Universidade de Aveiro, Aveiro, Portugal.

Celso A Reis (CA)

Institute of Biomedical Sciences Abel Salazar (ICBAS), University of Porto, 4050-013 Porto, Portugal.
Institute for Research and Innovation in Health (i3s) , University of Porto, 4200-135 Porto, Portugal.
Porto Comprehensive Cancer Centre (P.ccc), 4200-162 Porto, Portugal.
Institute of Molecular Pathology and Immunology of the University of Porto (IPATIMUP), Porto, Portugal.
Faculty of Medicine, University of Porto, Porto, Portugal.

Lúcio Lara Santos (LL)

Experimental Pathology and Therapeutics Group, Portuguese Institute of Oncology, 4200-162 Porto, Portugal.
Institute of Biomedical Sciences Abel Salazar (ICBAS), University of Porto, 4050-013 Porto, Portugal.
Digestive Cancer Research Group, 1495-161 Algés, Portugal.
Porto Comprehensive Cancer Centre (P.ccc), 4200-162 Porto, Portugal.
Department of Surgical Oncology, Portuguese Institute of Oncology of Porto, 4200-162 Porto, Portugal.

José Alexandre Ferreira (JA)

Experimental Pathology and Therapeutics Group, Portuguese Institute of Oncology, 4200-162 Porto, Portugal.
Institute of Biomedical Sciences Abel Salazar (ICBAS), University of Porto, 4050-013 Porto, Portugal.
Porto Comprehensive Cancer Centre (P.ccc), 4200-162 Porto, Portugal.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH